These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23569011)

  • 1. Plaque characteristics and serum pregnancy-associated plasma protein A levels predict the no-reflow phenomenon after percutaneous coronary intervention.
    Zhao XY; Wang XF; Li L; Zhang JY; Du YY; Yao HM
    J Int Med Res; 2013 Apr; 41(2):307-16. PubMed ID: 23569011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of plaque components analyzed by integrated backscatter intravascular ultrasound and serum pregnancy-associated plasma protein a levels predict the no-reflow phenomenon during percutaneous coronary intervention.
    Daidoji H; Takahashi H; Otaki Y; Tamura H; Arimoto T; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):43-50. PubMed ID: 24227626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
    Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
    Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.
    Li J; Wu L; Tian X; Zhang J; Shi Y
    PLoS One; 2015; 10(6):e0119223. PubMed ID: 26035818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual histology intravascular ultrasound analysis of attenuated plaque and ulcerated plaque detected by gray scale intravascular ultrasound and the relation between the plaque composition and slow flow/no reflow phenomenon during percutaneous coronary intervention.
    Amano H; Wagatsuma K; Yamazaki J; Ikeda T
    J Interv Cardiol; 2013 Jun; 26(3):295-301. PubMed ID: 23751079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque Composition and No-Reflow Phenomenon During Percutaneous Coronary Intervention of Low-Echoic Structures in Grayscale Intravascular Ultrasound.
    Amano H; Ikeda T; Toda M; Okubo R; Yabe T; Watanabe I; Saito D
    Int Heart J; 2016 May; 57(3):285-91. PubMed ID: 27170472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive performance of dual modality of computed tomography angiography and intravascular ultrasound for no-reflow phenomenon after percutaneous coronary stenting in stable coronary artery disease.
    Okutsu M; Horio T; Tanaka H; Akiyama M; Okimoto N; Tsubouchi T; Kawajiri K; Ohashi Y; Sumitsuji S; Ikari Y
    Heart Vessels; 2018 Oct; 33(10):1121-1128. PubMed ID: 29644449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the filter no-reflow phenomenon in patients with angina pectoris by using multimodality: Magnetic resonance imaging, optical coherence tomography, and serum biomarkers.
    Matsumoto K; Ehara S; Hasegawa T; Otsuka K; Yoshikawa J; Shimada K
    J Cardiol; 2016 May; 67(5):430-6. PubMed ID: 26265150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis.
    Hong YJ; Jeong MH; Choi YH; Ko JS; Lee MG; Kang WY; Lee SE; Kim SH; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Eur Heart J; 2011 Aug; 32(16):2059-66. PubMed ID: 19228713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the composition of atherosclerotic plaques and rate of platelet aggregation on elevation of serum levels of cardiac troponin T after percutaneous coronary interventions.
    Zhao XY; Wang XF; Zhang JY; Du YY; Yang HB
    J Interv Cardiol; 2012 Oct; 25(5):433-8. PubMed ID: 22724407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomographic angiography-verified plaque characteristics and slow-flow phenomenon during percutaneous coronary intervention.
    Kodama T; Kondo T; Oida A; Fujimoto S; Narula J
    JACC Cardiovasc Interv; 2012 Jun; 5(6):636-43. PubMed ID: 22721658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of distal embolization during percutaneous coronary intervention for unstable plaques with grayscale and integrated backscatter intravascular ultrasound.
    Shibuya M; Okamura A; Hao H; Date M; Higuchi Y; Nagai H; Ozawa M; Masuyama T; Iwakura K; Fujii K
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):E165-72. PubMed ID: 22777882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Quisi A; Alıcı G
    J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture.
    Soeda T; Higuma T; Abe N; Yamada M; Yokoyama H; Shibutani S; Ong DS; Vergallo R; Minami Y; Lee H; Okumura K; Jang IK
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):103-110. PubMed ID: 26800769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
    Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plaque composition and no-reflow phenomenon following primary angioplasty in patients with ST-segment elevation myocardial infarction--analysis with virtual histology intravascular ultrasound.
    Ohshima K; Ikeda S; Watanabe K; Yamane K; Izumi N; Ishibashi K; Ohshima K; Hamada M
    J Cardiol; 2009 Oct; 54(2):205-13. PubMed ID: 19782257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.